Why IT researchers choose Regena
Sourcing research peptides in Italy has historically meant choosing between under-documented offshore suppliers, opaque domestic re-sellers and compounding pharmacies pricing well above research-budget tolerances. Regena replaces all three with a verified-batch supply chain operated from inside the European Union: every vial ships with an independent third-party HPLC and mass-spectrometry COA, tracked tracked 2–3 working day courier service across IT, and a research-use declaration that satisfies customs handling on entry.
For IT laboratories the practical effect is shorter project timelines and cleaner experimental risk. A batch ordered Monday is typically on the bench within the week, with the COA already cross-referenced against the vial cap batch number. There is no compounding-pharmacy markup, no anonymous reseller in the middle of the chain, and no week-long wait for analytical paperwork after dispatch.
What ships to Italy
The full Regena catalogue is available for Italy delivery — GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide), growth-hormone secretagogues (CJC-1295, ipamorelin, tesamorelin, MK-677 reference material), regenerative compounds (BPC-157, TB-500, GHK-Cu, KPV), mitochondrial peptides (MOTS-c, SS-31) and the wider research catalogue. Vials are 2 mg, 5 mg, 10 mg and 15 mg formats depending on the compound.
Every IT shipment includes the printed COA, batch number, lot number and compound-specific reconstitution guidance. Bacteriostatic water, sterile water, mixing vials and insulin syringes can be added to the same order so a IT bench has everything it needs for a complete reconstitution workflow on arrival.
Delivery, customs and cold-chain to Italy
IT orders ship tracked from our European hub with a standard transit window of 2–3 working day. Dispatched from inside the EU customs union — no import duties, no VAT surprises and no border holds on Italian delivery. Vials travel in temperature-buffered mailers sized for the IT transit window so lyophilised product arrives within specification; refrigerate at 2–8 °C on arrival.
Express courier options are available through the consultations team for IT laboratories on tight project timelines. Delivery covers all of Italy including Rome, Milan, Naples, Turin, Florence, Bologna, Venice, Verona, Genoa and the broader Italian research community. Residential, co-working and registered research-entity addresses are all accepted.
Regulatory and research-use framing in Italy
Regena peptides are supplied strictly for in-vitro and preclinical research use. They are not medicines, are not approved for human consumption in Italy, and are not dispensed against a prescription. Italian research-use peptide supply sits outside AIFA-licensed medicinal-product regulation; nothing on the Regena catalogue is authorised by the AIFA for human use. The research-use declaration ships with every IT package and is sufficient for the courier and any internal procurement record.
IT researchers should ensure their work complies with the relevant institutional ethics framework and any local research-material handling rules. The Regena consultations team can pre-clear documentation questions before any vial is dispatched.
Independent verification on every IT batch
Every batch shipped to Italy ties back to an independent third-party COA hosted on the Regena lab reports page. Janoshik Analytical is the default verifier — the most widely cited independent peptide laboratory in Europe — with orthogonal laboratories used when batch chemistry calls for confirmation by a second method or when a IT institution requires a specific accredited laboratory.
Minimum specification for release is ≥99.0% HPLC main peak with matching mass-spectrometry molecular weight and water content within the published specification for the compound. Batches that do not meet the specification are not released, regardless of supply pressure on the IT channel.
IT research ecosystem and institutional buyers
Italy hosts a strong biomedical research network anchored in the CNR, the major university hospitals (Policlinico Gemelli, San Raffaele, Humanitas) and a fast-growing independent research clinic community across Milan, Rome and Florence. Regena's batch documentation slots directly into Italian institutional procurement workflows.
For multi-batch IT programmes — longitudinal stability studies, comparator panels, multi-cohort protocols — the consultations team will reserve inventory against a project timeline so an institutional buyer is not exposed to the wider catalogue's shifting availability. Material Safety Data Sheets, Certificates of Origin and Certificates of Conformity are supplied on request before dispatch.
Storage, reconstitution and in-use stability for IT laboratories
Lyophilised peptides delivered to Italy should be held at 2–8 °C on arrival; long-term storage at −20 °C is appropriate for batches that will not be reconstituted within 8–12 weeks. Reconstitution with bacteriostatic water (0.9% benzyl alcohol) supports a 28-day in-use stability window under refrigeration for most analogues — single-day work can use sterile water but should not be saved for repeat use.
Aliquot before any freeze. The single most common cause of measurable potency loss in long-acting analogues — semaglutide, tirzepatide, retatrutide — is repeat freeze-thaw cycling. Vortex gently, never shake aggressively, and keep reconstituted vials away from direct light. The /research/compound-storage-guide reference covers compound-specific stability windows for IT laboratories.
Working with Regena from Italy
A free 20-minute consultation is available to every IT researcher. The call covers compound selection, batch availability, COA review, reconstitution workflow and any project-specific stability or sourcing questions. The Regena scientific team handles consultations directly — there is no sales tier between a IT laboratory and the people who release the batch.
Book through the /consultations page; the team responds within one working day. For urgent IT requests, the same channel handles express dispatch quotes, inventory reservations and bespoke documentation requests.
Frequently asked questions
Do you ship research peptides to Italy?+
Yes — Regena ships every catalogue compound to Italy with tracked 2–3 working day courier service from our European hub.
Are the peptides legal in Italy?+
They are supplied strictly for in-vitro and preclinical research use. They are not medicines, are not approved for human consumption in Italy, and are not dispensed against a prescription.
Will I see an independent COA for every batch?+
Yes. Every batch carries a Janoshik (or equivalent independent) HPLC and mass-spectrometry COA, downloadable from the lab reports page and cross-referenced to the batch number on the vial cap.
How fast is delivery to Italy?+
Standard service is 2–3 working day tracked courier. Express options are available through the consultations team.
Are there customs or VAT issues for IT buyers?+
Dispatched from inside the EU customs union — no import duties, no VAT surprises and no border holds on Italian delivery.
Do IT universities receive institutional documentation?+
Yes — MSDS, CoO, CoC and ISO certificate references are supplied on request before dispatch.
Which compounds are available in Italy?+
The full Regena catalogue: GLP-1 agonists (semaglutide, tirzepatide, retatrutide), GH secretagogues (CJC-1295, ipamorelin, tesamorelin, MK-677), regenerative peptides (BPC-157, TB-500, GHK-Cu, KPV) and mitochondrial peptides (MOTS-c, SS-31).
Who verifies the batches sold in Italy?+
Janoshik Analytical is the default independent third-party verifier; orthogonal laboratories are used when batch chemistry calls for a second-instrument confirmation.
Recommended next — explore the catalogue
Hand-picked links our research customers most often open after this page.